Sign up to save your podcasts
Or
Share Neurovalens CEO Outlines Noninvasive Neuromodulation Plans
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Neurovalens CEO Outlines Noninvasive Neuromodulation Plans
Neurovalens’ Modius platform brings noninvasive neuromodulation into clinical practice, offering home-based FDA-authorized therapies for insomnia, anxiety, PTSD, and weight management, while facing evidence, reimbursement, and adoption challenges.
View all episodes
By TheBrief.HealthNeurovalens’ Modius platform brings noninvasive neuromodulation into clinical practice, offering home-based FDA-authorized therapies for insomnia, anxiety, PTSD, and weight management, while facing evidence, reimbursement, and adoption challenges.